Subscribe to Newsletter

Content by Stephanie Vine:

Manufacture Technology and Equipment

The Astropharmacy Concept

| Stephanie Vine

How do we make medicines in space? Lynn J. Rothschild explains how biologic medicines can be made on demand.

Discovery & Development Clinical Trials

Green Trials

| Stephanie Vine

Implementing green practices in clinical trials.

Discovery & Development Vaccines

The Pfizer COVID-19 Vaccine

| Stephanie Vine

Pfizer and BioNTech claim their two-dose COVID-19 mRNA vaccine (BNT162b2) is more than 90 percent effective.

Manufacture Contract Manufacturing Services

Getting the Job (Done)

| Stephanie Vine

Sitting Down With… Will Downie, CEO of Vectura Group, UK, to discuss his career and passion for business.

Manufacture Small Molecules

Think Small

| Stephanie Vine

Researchers create micro-feeder that eases the handling of small quantities of powder.

Manufacture COVID-19

Fancy a Game of Ping-Pong?

| Stephanie Vine

When following COVID-19 research, it’s hard to keep your eye on the ball...

Discovery & Development Drug Discovery

Mass Spec Meets Machine learning

| Stephanie Vine

Can machine learning offer mass spectrometry a boost for drug discovery?

Business & Regulation Business Practice

Business in Brief

| Stephanie Vine

Power testing partnership, NASH breakthrough designation, and new CEO appointments. What’s new for pharma in business?

Discovery & Development Clinical Trials

Pandemic Protection

| Stephanie Vine

Fujifilm Toyama's influenza treatment passes COVID-19 trial.

Manufacture Vaccines

Don’t Exclude the Aged

| Stephanie Vine

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register